Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - Aeglea BioTherapeutics, Inc. | agle-ex322_6.htm |
EX-32.1 - EX-32.1 - Aeglea BioTherapeutics, Inc. | agle-ex321_13.htm |
EX-31.2 - EX-31.2 - Aeglea BioTherapeutics, Inc. | agle-ex312_14.htm |
EX-31.1 - EX-31.1 - Aeglea BioTherapeutics, Inc. | agle-ex311_11.htm |
EX-23.1 - EX-23.1 - Aeglea BioTherapeutics, Inc. | agle-ex231_12.htm |
EX-4.5 - EX-4.5 - Aeglea BioTherapeutics, Inc. | agle-ex45_732.htm |
10-K - 10-K - Aeglea BioTherapeutics, Inc. | agle-10k_20191231.htm |
Exhibit 21.1
Subsidiaries of Aeglea BioTherapeutics, Inc.
|
|
|
Name of Subsidiary |
|
Jurisdiction |
Aeglea Development Company, Inc. |
|
Delaware |
|
|
|
AERase, Inc. |
|
Delaware |
|
|
|
AECase, Inc. |
|
Delaware |
|
|
|
AEMase, Inc. |
|
Delaware |
|
|
|
AE4ase, Inc. |
|
Delaware |
|
|
|
AE5ase, Inc. |
|
Delaware |
|
|
|
AE6ase, Inc. |
|
Delaware |
|
|
|
Aeglea Biotherapeutics UK Limited |
|
England and Wales |
|